Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.


Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.

More about this publication

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
  • Volume 44
  • Issue nr. 3
  • Pages e431608
  • Publication date 01-06-2024

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.